[go: up one dir, main page]

MX2008010804A - Derivados de rapamicina para tratar neuroblastoma. - Google Patents

Derivados de rapamicina para tratar neuroblastoma.

Info

Publication number
MX2008010804A
MX2008010804A MX2008010804A MX2008010804A MX2008010804A MX 2008010804 A MX2008010804 A MX 2008010804A MX 2008010804 A MX2008010804 A MX 2008010804A MX 2008010804 A MX2008010804 A MX 2008010804A MX 2008010804 A MX2008010804 A MX 2008010804A
Authority
MX
Mexico
Prior art keywords
rapamycin derivatives
treating neuroblastoma
neuroblastoma
treating
rapamycin
Prior art date
Application number
MX2008010804A
Other languages
English (en)
Inventor
Hans Schaller
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2008010804A publication Critical patent/MX2008010804A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un derivado de rapamicina para uso en el tratamiento de neuroblastoma, opcionalmente en combinación con una segunda sustancia de fármaco.
MX2008010804A 2006-02-24 2007-02-22 Derivados de rapamicina para tratar neuroblastoma. MX2008010804A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0603782.4A GB0603782D0 (en) 2006-02-24 2006-02-24 Organic compounds
PCT/EP2007/001551 WO2007096174A1 (en) 2006-02-24 2007-02-22 Rapamycin derivatives for treating neuroblastoma

Publications (1)

Publication Number Publication Date
MX2008010804A true MX2008010804A (es) 2008-10-31

Family

ID=36178746

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008010804A MX2008010804A (es) 2006-02-24 2007-02-22 Derivados de rapamicina para tratar neuroblastoma.

Country Status (12)

Country Link
US (1) US20090023768A1 (es)
EP (1) EP1988894A1 (es)
JP (1) JP2009527520A (es)
KR (1) KR20080100346A (es)
CN (1) CN101389337A (es)
AU (1) AU2007217705A1 (es)
BR (1) BRPI0708160A2 (es)
CA (1) CA2642243A1 (es)
GB (1) GB0603782D0 (es)
MX (1) MX2008010804A (es)
RU (1) RU2008137723A (es)
WO (1) WO2007096174A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2589383A1 (en) 2011-11-06 2013-05-08 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin FKBP subtype-specific rapamycin analogue for use in treatment of diseases

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102268015B (zh) * 2011-08-30 2013-08-28 成都摩尔生物医药有限公司 一种依维莫司的合成方法
UY37900A (es) * 2017-09-26 2019-04-30 Novartis Ag Nuevos derivados de rapamicina
AU2019409366B2 (en) 2018-12-18 2022-10-27 Novartis Ag Rapamycin derivatives
PT3947392T (pt) * 2019-03-26 2024-05-14 Novartis Ag Derivados de rapamicina contendo 1,1-dióxido de isotiazolidina e 1,4-butano sultona e seus usos
CN113181117B (zh) * 2021-03-22 2022-08-26 沈阳药科大学 一种紫草素和蒽环类化疗药共载脂质体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0210101A (pt) * 2001-06-01 2004-06-08 Wyeth Corp Combinações antineoplásticas
AU2003241359A1 (en) * 2002-05-06 2003-11-11 Functional Genetics, Inc. Mammalian genes involed in rapamycin resistance and tumorgenesis: annexin xiii genes
WO2004004644A2 (en) * 2002-07-05 2004-01-15 Beth Israel Deaconess Medical Center Combination of mtor inhibitor and a tyrosine kinase inhibitor for the treatment of neoplasms
GB0217777D0 (en) * 2002-07-31 2002-09-11 Novartis Ag Organic compounds
US20060099676A1 (en) * 2002-08-15 2006-05-11 Limin Li Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
GB0327840D0 (en) * 2003-12-01 2003-12-31 Novartis Ag Organic compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2589383A1 (en) 2011-11-06 2013-05-08 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin FKBP subtype-specific rapamycin analogue for use in treatment of diseases
WO2013064703A2 (en) 2011-11-06 2013-05-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Fkbp subtype-specific rapamycin analogue for use in treatment of diseases

Also Published As

Publication number Publication date
AU2007217705A1 (en) 2007-08-30
BRPI0708160A2 (pt) 2011-05-17
GB0603782D0 (en) 2006-04-05
JP2009527520A (ja) 2009-07-30
KR20080100346A (ko) 2008-11-17
RU2008137723A (ru) 2010-03-27
EP1988894A1 (en) 2008-11-12
CN101389337A (zh) 2009-03-18
CA2642243A1 (en) 2007-08-30
WO2007096174A1 (en) 2007-08-30
US20090023768A1 (en) 2009-01-22

Similar Documents

Publication Publication Date Title
IL192648A0 (en) Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
CY1120741T1 (el) Θεραπεια οζωδους σκληρυνσης
CL2008002540A1 (es) Compuestos derivados aza-indol-2,3-sustituidos; composicion farmaceutica; y uso ene l tratamiento de una infeccion viral.
IL193467A0 (en) Substituted indazole derivatives, their manufacture and use as pharmaceutical agents
TW200738725A (en) Unsaturated mTOR inhibitors
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
IL197316A0 (en) Buprenophine-wafer for drug substitution therapy
EP3542629A3 (en) Dithiol compounds, derivatives, and uses therefor
CL2007003444A1 (es) Compuestos derivados de pirrolo[3,2-c]piridina; composicion farmaceutica; y uso en el tratamiento de un trastorno hiperproliferativo o una enfermedad inflamatoria.
EP2023926A4 (en) PYRIDONECARBOXAMIDE DERIVATIVES USEFUL FOR TREATING HYPERPROLIFERATIVE AND ANGIOGENESIS RELATED DISORDERS
CL2007001435A1 (es) Compuestos derivados de fenilalanina; proceso de prepatacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto como inhibidores de integrina para el tratamiento del cancer.
HUE059861T2 (hu) N-Szubsztituált 2,5-dioxo-azolin vegyületek a rák kezelésében való felhasználásra
EP2157093A4 (en) HETEROCYCLIC PYRROLO-NITROGEN-DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL USE
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
IL198112A0 (en) 3-aminoimidazo [1,2-a]pyridine derivatives having an sglt1-and sglt2-inhibiting action for the treatment of type 1 and type 2 diabetes
PL2401263T3 (pl) Podstawione pochodne azotu, zawierająca pochodne kompozycja farmaceutyczna, i sposób leczenia choroby Parkinsona przy ich użyciu
MX2008010804A (es) Derivados de rapamicina para tratar neuroblastoma.
SI1994005T1 (sl) Tetrahidronaftalenski derivati postopek za njihovo pripravo in njihova uporaba kot protivnetna sredstva
IL185377A0 (en) Method for a medicinal combination treatment, and medicament combinations suitable therefor
IL190596A0 (en) 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
JO2730B1 (en) Medications for the treatment of endometriosis
EP1894588A4 (en) NEEDLE FOR MEDICAL TREATMENT
IL197125A0 (en) Drug combinations for treating airway diseases
PT1976826T (pt) Derivados orgânicos, seus sais e seu uso relativo para o controlo de fitopatogénios
BRPI0808035A2 (pt) uso de inibidores da degradação de p27, em particular argirina e derivados da mesma, para o tratamento de doenças proliferativas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal